Literature DB >> 32548895

Transporters HP0939, HP0497, and HP0471 participate in intrinsic multidrug resistance and biofilm formation in Helicobacter pylori by enhancing drug efflux.

Yuying Cai1,2, Caixia Wang1,2, Zhenghong Chen1, Zhengzheng Xu3, Huanjie Li3, Wenjuan Li3, Yundong Sun3.   

Abstract

BACKGROUND: The multidrug resistance of Helicobacter pylori is becoming an increasingly serious issue. It is therefore necessary to study the mechanism of multidrug resistance of H pylori. We have previously identified that the HP0939, HP0497, and HP0471 transporters affect the efflux of drugs from H pylori. As efflux pumps participate in bacterial multidrug resistance and biofilm formation, we hypothesized that these transporters could be involved in the multidrug resistance and biofilm formation of H pylori.
MATERIALS AND METHODS: We therefore constructed three knockout strains, Δhp0939, Δhp0497, and Δhp0471, and three high-expression strains, Hp0939he , Hp0497he , and Hp0471he , using the wild-type (WT) 26 695 strain of H pylori as the template. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of wild strains, knockout strains, and high-expression strains to amoxicillin, metronidazole, and other antibiotics were measured. The efflux capacity of high-expression strains and wild strains was compared by Hoechst 33 342 accumulation assay.
RESULTS: Determination of the MIC and MBC of the antibiotics revealed that the knockout strains were more sensitive to antibiotics, while the high-expression strains were less sensitive to antibiotics, compared to the WT. The ability of the high-expression strains to efflux drugs was significantly higher than that of the WT. We also induced H pylori to form biofilms, and observed that the knockout strains could barely form biofilms and were more sensitive to several antibiotics, compared to the WT. The mRNA expression of hp0939, hp0497, and hp0471 in the clinically sensitive and multidrug-resistant strains was determined, and it was found that these genes were highly expressed in the multidrug-resistant strains that were isolated from the clinics.
CONCLUSIONS: In this study, we found three transporters involved in intrinsic multidrug resistance of H pylori.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990H pylorizzm321990; biofilm; efflux pump; multidrug resistance; transporter

Mesh:

Substances:

Year:  2020        PMID: 32548895     DOI: 10.1111/hel.12715

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  5 in total

Review 1.  Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Clin Microbiol Rev       Date:  2022-04-11       Impact factor: 50.129

2.  Biofilm Formation of Helicobacter pylori in Both Static and Microfluidic Conditions Is Associated With Resistance to Clarithromycin.

Authors:  Paweł Krzyżek; Paweł Migdał; Rossella Grande; Grażyna Gościniak
Journal:  Front Cell Infect Microbiol       Date:  2022-03-25       Impact factor: 6.073

3.  Antimicrobial resistance patterns and genetic elements associated with the antibiotic resistance of Helicobacter pylori strains from Shanghai.

Authors:  Yixin Liu; Su Wang; Feng Yang; Wenjing Chi; Li Ding; Tao Liu; Feng Zhu; Danian Ji; Jun Zhou; Yi Fang; Jinghao Zhang; Ping Xiang; Yanmei Zhang; Hu Zhao
Journal:  Gut Pathog       Date:  2022-03-30       Impact factor: 4.181

Review 4.  Helicobacter pylori Biofilm-Related Drug Resistance and New Developments in Its Anti-Biofilm Agents.

Authors:  Chong Hou; Fangxu Yin; Song Wang; Ailing Zhao; Yingzi Li; Yipin Liu
Journal:  Infect Drug Resist       Date:  2022-04-05       Impact factor: 4.003

5.  Phillygenin Inhibits Helicobacter pylori by Preventing Biofilm Formation and Inducing ATP Leakage.

Authors:  Ru-Jia Li; Chun Qin; Gan-Rong Huang; Li-Juan Liao; Xiao-Qiang Mo; Yan-Qiang Huang
Journal:  Front Microbiol       Date:  2022-04-28       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.